Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease

Journal of the American Society of Nephrology

Volumn 10, Issue 3, 1999, Pages 594-600

  Kielstein, Jan T ^a   Böger, Rainer H ^a   Bode Böger, Stefanie M ^a   Schäffer, Jürgen ^a   Barbey, Mark ^a   Koch, Karl M ^a   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK FACTOR; URINARY EXCRETION;

EID: 0344791653     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993
2. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H: Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions. Hypertension (Dallas) 23: 1121-1131, 1994
3. Rees DD, Palmer RM, Hodson HF, Moncada S: A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 96: 418-424, 1989
4. Vallance P, Leone A, Calver A, Collier J, Moncada S: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20[Suppl 12]: S60-S62, 1992
5. MacAllister RJ, Fickling SA, Whitley GS, Vallance P: Metabolism of methylarginines by human vasculature: Implications for the regulation of nitric oxide synthesis. Br J Pharmacol 112: 43-48, 1994
6. G-dimethylarginine in the rabbit. Biochem J 154: 179-184, 1976
7. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
8. Kurose I, Wolf R, Grisham MB, Granger DN: Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol 268: H2224-H2231, 1995
9. Faraci FM, Brian JEJ, Heistad DD: Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 269: H1522-H1527, 1995
10. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074, 1997
11. National Kidney Foundation DOQI: Clinical Practice Guidelines for Hemodialysis Adequacy, New York, National Kidney Foundation, 1997, pp 42-46
12. National Kidney Foundation DOQI: Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, New York, National Kidney Foundation, 1997, pp 46-47
13. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC: Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219: 598-603, 1996
14. 15N-labelled analogs. J Chromatogr B Biomed Appl 661: 185-191, 1994
15. MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E: Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11: 2449-2452, 1996
16. G-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8: 1437-1442, 1997
17. Böger RH, Bode-Böger SM, Tsao PS, Lin Chan JR, Cooke JP: The endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) exerts pro-atherosclerotic effects in cultured human endothelial cells [Abstract]. Circulation 96: 1-1588, 1997
18. G-dimethylarginine by human endothelial cells. Endothelium 1: 137, 1998
19. G-dimethylarginine in rats. Arch Biochem Biophys 252: 526, 1987
20. G-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 300: 657-662, 1993
21. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 117: 237-238, 1995
22. Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T, Vallance P, Wilcox CS: Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 52: 1593-1601, 1997
23. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GS, Vallance P: Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119: 1533-1540, 1996
24. Joannides R, Bakkali EH, Le RF, Rivault O, Godin M, Moore N, Fillastre JP, Thuillez C: Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 12: 2623-2628, 1997
25. Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L: Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52: 468-472, 1997
26. Hand MF, Haynes WG, Webb DJ: Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 53: 1068-1077, 1998
27. Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Böhme M, Nafe R, Mügge A, Frölich JC: Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: Comparison with lovastatin. Circulation 96: 1282-1290, 1997
28. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskopf I, Kaplan E, Silverberg D, Cabili S, Iania A: Low nitric oxide production in patients with chronic renal failure. Nephron 79: 265-268, 1998
29. Rysz J, Luciak M, Kedziora J, Blaszczyk J, Sibinska E: Nitric oxide release in the peripheral blood during hemodialysis. Kidney Int 51: 294-300, 1997
30. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 123: 35-37, 1995
31. Rhodes P, Leone A, Francis P, Struthers A, Moncada S: The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209: 590-596, 1995
32. Maiorca R: Cardiovascular problems in the choice of dialysis therapy for the elderly. Contrib Nephrol 106: 74-83, 1994
33. Maiorca R, Cancarini GC, Zubani R, Movilli E, Brunori G: Differing dialysis treatment strategies and outcome [Review]. Nephrol Dial Transplant 11 [Suppl 2]: 134-139, 1996
34. Maiorca R, Cancarini GC, Brunori G, Zubani R, Camerini C, Manili L, Movilli E: Comparison of long-term survival between hemodialysis and peritoneal dialysis [Review]. Adv Perit Dial 12: 79-88, 1996
35. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992
36. Cayatte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14: 753-759, 1994
37. 2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb 14: 746-752, 1994
38. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Cooke JP: Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98: 1842-1847, 1998
39. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
40. London GM, Drüeke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51: 1678-1695, 1997
41. Attman PO, Samuelsson O, Alaupovic P: Progression of renal failure: Role of apolipoprotein B-containing lipoproteins. Kidney Int Suppl 63: S98-S101, 1997
42. Nishizawa Y, Shoji T, Kawagishi T, Morii H: Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int Suppl 62: S90-S92, 1997
43. Wanner C, Zimmermann J, Quaschning T, Galle J: Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int Suppl 62: S53-S55, 1997
44. Gupta A, Robinson K: Hyperhomocysteinaemia and end stage renal disease. J Nephrol 10: 77-84, 1997